Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy (Q28478110)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

main subject

anti-retroviral agent

0 references

1 reference

Mar Pujades-Rodríguez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Loretxu Pinoges

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

René Ecochard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jean-François Etard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Esther Carrillo-Casas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Elisabeth Szumilin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

AIDS Working Group of Médecins Sans Frontières

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

21 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

e28112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

17 January 2020

start time

21 November 2011

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Peripheral neuropathy in HIV: prevalence and risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221698

Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221698

Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221698

Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221698

Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221698

Design and implementation of the stavudine parallel-track program

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221698

2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221698

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221698

HIV-associated sensory neuropathies.

2 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

Risk modifiers for peripheral sensory neuropathy in HIV infection/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

Reductions in stavudine dose might ameliorate mitochondrial-associated complications without compromising antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

HIV neuropathy natural history cohort study: Assessment measures and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0028112

The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221698

Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active antiretroviral therapy regimens in Western India.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221698

Threshold effect and tissue specificity. Implication for mitochondrial cytopathies

27 November 2018

1 reference

12 December 2020

Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175/801 Study Team

1 reference

12 December 2020

Distal sensory polyneuropathy in HIV-positive patients in the HAART era: an entity underestimated by clinical examination

1 reference

12 December 2020

Incidence of and risk factors for HIV-associated distal sensory polyneuropathy

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0028112

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

22132226

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22132226%20AND%20SRC:MED&resulttype=core&format=json